Search

Arvin Dar Phones & Addresses

  • New York, NY
  • San Francisco, CA

Publications

Us Patents

Methods And Compositions For Modulating Ire1, Src, And Abl Activity

View page
US Patent:
20110319436, Dec 29, 2011
Filed:
Sep 15, 2009
Appl. No.:
13/119162
Inventors:
Peter Walter - San Francisco CA, US
Alexei Korennykh - San Francisco CA, US
Kevan M. Shokat - San Francisco CA, US
Chao Zhang - Santa Cruz CA, US
Robert Stroud - San Francisco CA, US
Pascal Egea - San Francisco CA, US
Andrei Korostelev - Santa Cruz CA, US
Arvin Dar - San Francisco CA, US
Sebastian Bernales - Santiago, CL
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 31/517
C07D 403/12
C07D 409/14
C07D 417/14
A61K 31/506
C12N 5/071
A61K 31/404
A61P 35/00
A61P 29/00
A61P 25/00
A61P 3/10
A61P 27/02
A61P 25/28
A61P 25/16
C12Q 1/48
C07D 403/14
US Classification:
51426623, 544324, 544284, 514275, 435375, 514414, 436 86, 435 61
Abstract:
Disclosed herein are, inter alia, compositions for modulating Ire1, Src, or Abl, methods for identifying modulating activity in test compounds, and methods for treating diseases caused by the activity or inactivity of Ire1, Src, or Abl.

Methods Of Inhibiting Ire1

View page
US Patent:
20120322814, Dec 20, 2012
Filed:
Oct 18, 2010
Appl. No.:
13/502307
Inventors:
Alexei Korennykh - Princeton NJ, US
Peter Walter - San Francisco CA, US
Han Li - Redwood City CA, US
Arvin Dar - San Francisco CA, US
Kevan Shokat - San Francisco CA, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA - Oakland CA
International Classification:
C12N 9/99
A61P 1/04
A61P 35/04
A61K 31/519
A61P 37/00
US Classification:
5142621, 435184
Abstract:
Disclosed herein are, inter alia, methods for inhibiting Ire1 activity.

Fused Ring Heteroaryl Kinase Inhibitors

View page
US Patent:
20110275651, Nov 10, 2011
Filed:
Oct 16, 2009
Appl. No.:
13/124657
Inventors:
Arvin Dar - San Francisco CA, US
Kevan M. Shokat - San Francisco CA, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA - Oakland CA
International Classification:
A61K 31/519
A61P 43/00
A61P 35/00
A61P 35/02
C12N 9/99
C07D 487/04
US Classification:
5142621, 435184, 544262
Abstract:
Provided herein are fused ring heteroaryl compounds useful in a variety of methods, including reducing the activity of certain kinases and treating certain disease states.

Methods And Compositions For Modulating Ire1, Src, And Abl Activity

View page
US Patent:
20150011575, Jan 8, 2015
Filed:
Jul 2, 2014
Appl. No.:
14/322765
Inventors:
- Oakland CA, US
Alexei Korennykh - San Francisco CA, US
Kevan M. Shokat - San Francisco CA, US
Chao Zhang - Santa Cruz CA, US
Robert Stroud - San Francisco CA, US
Pascal Egea - San Francisco CA, US
Andrei Korostelev - Santa Cruz CA, US
Arvin Dar - San Francisco CA, US
Sebastian Bernales - Santiago, CL
International Classification:
C07D 403/12
US Classification:
514275
Abstract:
Disclosed herein are, inter alia, compositions for modulating Ire1, Src, or Abl, methods for identifying modulating activity in test compounds, and methods for treating diseases caused by the activity or inactivity of Ire1, Src, or Abl.
Arvin Dar from New York, NY, age ~47 Get Report